Bausch Health Companies Inc.
Company Stats
- Market Cap
- $2.2B
- as of Sep 30, 2026
- Enterprise Value
- $21.1B
- Shares Outstanding
- 374.0M
- Free Float
- 45.3%
Income Statement
- Revenue
- $10.3B
- Operating Income
- $1.8B
- Net Income
- $157.0M
- EBITDA
- $2.0B
- Non-cash Impairment
- $8.0M
- Revenue Growth, 3Y
- 8.1%
- FCF Margin, 3Y Avg
- 10.7%
- FCF Margin, Worst Year
- 9.3%
Cash Flow
- Free Cash Flow
- $1.0B
- FCF Yield
- 46.0%
- Owner FCF Yield
- 36.1%
Balance Sheet
- Cash & Equivalents
- $1.3B
- Total Debt
- $20.2B
- Net Debt
- $18.9B
- Net Debt / EBITDA
- 9.37x
- EV / EBITDA
- 10.45x
- Net Debt / EBIT
- 10.44x
Returns & Capital
- SBC, 3Y Avg
- $166.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $10.3B | $1.0B | 9.8% |
| FY2024 | $9.6B | $1.3B | 13.1% |
| FY2023 | $8.8B | $817.0M | 9.3% |
| FY2022 | $8.1B | -$946.0M | -11.6% |
| FY2021 | $8.4B | $1.2B | 13.7% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 8, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back